Genetic Predisposition to Long-Term Nondiabetic Deteriorations in Glucose Homeostasis
Authors:
- Dmitry ShunginDSDmitry Shungin
- the MAGIC InvestigatorsTIthe MAGIC Investigators
- Paul W. FranksPFPaul W. Franks
Open Access
- 24 September 2010
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 60 (1) , 345-354
Abstract
OBJECTIVE: To assess whether recently discovered genetic loci associated with hyperglycemia also predict long-term changes in glycemic traits.RESEARCH DESIGN AND METHODS: Sixteen fasting glucose-raising loci were genotyped in middle-aged adults from the Gene x Lifestyle interactions And Complex traits Involved in Elevated disease Risk (GLACIER) Study, a population-based prospective cohort study from northern Sweden. Genotypes were tested for association with baseline fasting and 2-h postchallenge glycemia (N = 16,330), and for changes in these glycemic traits during a 10-year follow-up period (N = 4,059).RESULTS: Cross-sectional directionally consistent replication with fasting glucose concentrations was achieved for 12 of 16 variants; 10 variants were also associated with impaired fasting glucose (IFG) and 7 were independently associated with 2-h postchallenge glucose concentrations. In prospective analyses, the effect alleles at four loci (GCK rs4607517, ADRA2A rs10885122, DGKB-TMEM195 rs2191349, and G6PC2 rs560887) were nominally associated with worsening fasting glucose concentrations during 10-years of follow-up. MTNR1B rs10830963, which was predictive of elevated fasting glucose concentrations in cross-sectional analyses, was associated with a protective effect on postchallenge glucose concentrations during follow-up; however, this was only when baseline fasting and 2-h glucoses were adjusted for. An additive effect of multiple risk alleles on glycemic traits was observed: a weighted genetic risk score (80th vs. 20th centiles) was associated with a 0.16 mmol/l (P = 2.4 × 10−6) greater elevation in fasting glucose and a 64% (95% CI: 33–201%) higher risk of developing IFG during 10 years of follow-up.CONCLUSIONS: Our findings imply that genetic profiling might facilitate the early detection of persons who are genetically susceptible to deteriorating glucose control; studies of incident type 2 diabetes and discrete cardiovascular end points will help establish whether the magnitude of these changes is clinically relevant.Keywords
This publication has 38 references indexed in Scilit:
- Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish populationDiabetologia, 2010
- Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challengeNature Genetics, 2010
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- Adverse metabolic and cardiovascular consequences of circadian misalignmentProceedings of the National Academy of Sciences, 2009
- Replication and extension of genome-wide association study results for obesity in 4923 adults from northern SwedenHuman Molecular Genetics, 2009
- Variants in MTNR1B influence fasting glucose levelsNature Genetics, 2008
- Genome-wide association analysis of metabolic traits in a birth cohort from a founder populationNature Genetics, 2008
- Genotype Score in Addition to Common Risk Factors for Prediction of Type 2 DiabetesNew England Journal of Medicine, 2008
- The Meter of MetabolismCell, 2008
- Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populationsDiabetologia, 2007